Document 7173466

Download Report

Transcript Document 7173466

Neonatology: Hypoxic-Ischemic Encephalopathy, HIE

Main Contents

     

Clinical definition Etiology/High risk factors Pathogenesis and Pathophysiology Clinical manifestations and diagnostic Neuroimaging Prognosis Clinical Management

Clinical definition

Brain damage in Fetus and neonates caused by hypoxic and/or decreasing or abruption of blood flow to brain during perinatal period.

Etiology

Almost all the factors causing asphyxia resulting HIE, and

–

Maternal

–

Placenta and umbilicus abnormality

–

Substantial pulmonary, cardiac and CNS disease of the fetus and neonates

–

Pronged partum

–

Medication during delivering

High risk factors

• • • • •

Prolonged fetal bradycardia Repeated late decelerations Low Apgar scores at 5 minutes or later Low fetal scalp or cord pH Requirement for prolonged resuscitation with positive-pressure ventilation

Pathogenesis and Pathophysiology

•

Change of cerebral blood flow

–

normal term stable CBF: 50-60ml/min/100g

–

CBF

<

20ml/min /100g, brain damage

Pathogenesis and Pathophysiology

•

Change of cerebral metabolism

– –

Increase in anaerobic glycolysis Na + , Ca2 + pump function

 –

intracellular ATP exhausted Na + , Ca2 + endosmosis

Irritability amino acid

 –

blocking oxidative phosphorylation in mitochondrion blood stream reperfusion

radical

oxygen free

Pathogenesis and Pathophysiology

•

Change of nuropathology

–

Term baby: cortex infarction gray matter in partes profunda necrosis

–

Preterm: intraventricular haemorrhage white matter injury

–

Cerebral inflammation IL-1, TNF-

, CKs

Cellular apoptosis

Clinical manifestations

•

Mild

–

excitation/ irritability

–

Apparent at 24 hr

–

No convulsion

–

normal EEG

Clinical manifestations

•

Moderate

–

Convulsion, 50%

–

with disorder of consciousness

–

Apparent at 24-48 hr

–

Deterioration: intensity of anterior fontanelle

–

coma

Clinical manifestations

•

Severe

–

light coma or coma at birth

–

Irregular respiration and apnea

–

Convulsion with 12 hr

–

Poor muscle tone

–

Intensity of anterior fontanelle

–

Most die in 1 week

–

Survivors with severe nerosequelees

HIE

的诊断

—

临床表现

中华医学会儿科学会新生儿学组

2004

年

11

月修订

;

长沙 1. 胎儿宫内窒息史,严重的胎儿宫内窘迫表现 (胎心<100次,持续5分钟以上;和/或羊水III度污染) 2. 出生时有重度窒息:(Apgar评分1分钟≤ 3分) 至5分钟时仍≤ 5分;或出生时脐动脉血气pH ≤ 7.00 ; 3、出生后24 小时内出现神经系统表现; 4、排除低钙血症、低糖血症、感染、产伤和颅内出血等引 起的抽搐,以及遗传代谢性疾病和其他先天性疾病所引 起的神经系统疾患。 • 同时具备以上4条者可确诊,第4条暂时不能确定者作为 拟诊病例。

HIE

的诊断

—

脑电图

• • • • 中华医学会儿科学会新生儿学组 2004年11月 长沙修订 在生后

1

周内检查 脑电图异常程度与临床分度基本一致 脑电图异常表现: 脑电活动延迟 背景活动异常

(

落后于实际胎龄

)

,

(

以低电压和爆发抑制为主

)

振幅整合脑电图

(aEEG)

HIE

的诊断

—

影象学检查

• • • 中华医学会儿科学会新生儿学组

2004

年

11

月修订

;

长沙 头颅

B

超 可在

HIE

病程早期

(72

小时内

)

开始检查 有利于了解脑水肿、基底神经节丘脑损伤 和脑动脉梗死等病理改变

CT

生后

4-7

天为宜

MRI

对

HIE

病变性质与程度评价方面优于

CT

Cerebral edema

Neuroimaging

US

Cerebral edema

Neuroimaging

CT MRI

Neuroimaging

US

•

injury in Hypothalamus and Basal ganglia

Neuroimaging

injury in Hypothalamus and Basal ganglia

CT MRI

Neuroimaging

injury in Area adjacent to the sagittal

CT MR I

Neuroimaging

US

早期回声增强

Cerebral artery Infarction in terms

Neuroimaging

Cerebral artery Infarction in terms

CT MR I

Neuroimaging

PVL in premature

US

Neuroimaging

PVL in premature

CT MRI

Neuroimaging

Punctate encephalon haemorrhage

MRI

Severity and diagnosis

• • • 中华医学会儿科学会新生儿学组

2004

年

11

月修订

;

长沙

Mild

–

Irritability, normal tone..

–

Moro’s:

; Sucking: normal

–

normal respiration

,

no convulsion Moderate

–

Oppressed

,

muscle tone

 ,

Moro’s and Sucking

 –

convulsion

。

>7-10d, may have sequelae severe

–

coma

,

frequently convulsion

–

irregular respiration or apnea. respiration failure. very high death rate

–

Survivors usually have sequelae

Prognosis

•

Mild and Moderate Recovered <5d, good outcome

•

Middle >7d,or Severe worse outcome

Clinical Management

•

For an asphyxiated newborn:

–

immediate maintenance of ventilation and perfusion

–

control of seizures

–

maintenance of metabolic homeostasis, especially blood glucose levels to avoid additional cerebral insult

Clinical Management

• • • •

Maintenance of adequate ventilation:

–

Avoidance of hypoxemia and hypercapnia To avoid systemic hypotension

–

cerebral perfusion Prevention of fluid overload:

–

current data in human newborns do not provide convincing evidence that supports the use of antiedema therapy Maintenance of normoglycemia

Clinical Management

• • •

Control seizures

–

begin with a loading dose of phenobarbital (20mg/kg) ,IV

–

followed by additional 5-mg/kg, total dose 40 mg/kg For refractory seizures:

–

lorazepam by IV may be indicated Recent recommendations emphasis:

–

brief duration of treatment; possible deleterious effects of anticonvulsants on the developing nervous system.

Clinical Management

•

Cool Cap (Selective Head Hypothermia Therapy)

–

Multi-center trial

: –

US, Canada, UK and New Zealand: 25

–

Sample: trial/control=116/118

• •

Apgar<=6/5min+Cord arterial ph <7.1

clinical HIE+EEG abnormal

–

aEEG severe: (n=46)

:

not effective

–

aEEG Moderate : (n=172); showed protective

Gluckman PD, Cool Cap trial group. Lancet 2005

Clinical Management

• •

Cool Cap (Selective Head Hypothermia Therapy) aEEG Moderate : (n=172); showed protective

– –

Death rate: severe neromotion disabled 48% vs 66% p=0.02

–

Bayley MDI: 85 vs 77 p=0.04

–

Bayley PDI: 90 vs 85 p=0.047

Gluckman PD, Cool Cap trial group. Lancet 2005

Clinical Management

• • • •

Whole body Hypothermia NIH Neonatal Network,US Multi-center

:

16, sample

:

208 Results;

– –

Death: 24%(H) vs 36% p=0.08

middle or severe disabled

•

45%(H) vs 62%(N) p=0.01

(OR: 0.72, 95% CI 0.55-0.93)

Shankaran et al

:

National Institute of Child Health and Human Development Neonatal Research Network.

Whole -body hypothermia for neonates with hypoxic-ischemicencephalopathy.

NEJM 2005 Oct 13;353(15):1574-84.

Summery

• •

HIE is the major cause of the neonatal death

•

Asphyxia and ischemia hypoxemia in perinatal resulting in HIE

•

Diagnosis based on clinical manifestation and may combined with Neuroimaging Though there are some therapies for HIE treatments for HIE is still not as effective as expected

Thanks and questions?